News
The Health and Human Services Department would look a lot different, and spend a lot less money, under a plan the White House ...
Elon Musk was getting high on ketamine, psychedelics, Adderall, and ecstasy frequently while on the campaign trail for ...
Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...
The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...
Following through on President Donald Trump’s “most favored nation” policy, the HHS is about to drop a drug pricing hammer on ...
The company has started to add bearish views on Wall Street as the healthcare giant's business practices draw public scrutiny, risking its prospects, worsened by its recent leadership change. Bank of ...
We can move toward free market reforms in drug pricing. We must overturn the current perverse incentives that favor the ...
A new government-issued report reflects some of the most controversial views on vaccines, the nation’s food supply, ...
It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ...
But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending ...
President Donald Trump recently signed an executive order aimed at lowering prescription drug prices. However, experts told KFF Health News the policy’s rollout reveals a slow, conditional path that ...
As part of a broader resurgence in pharmaceutical pricing reform and manufacturing policies in 2025, President Donald Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results